SCHEMBL6206846

SCHEMBL6206846

NC(=C(C(=O)O)C(=O)c1ccccc1)C(F)(F)F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES1 P23141 11/20 0.48
CES2 O00748 10/20 0.46
L3MBTL1 Q9Y468 2/20 0.43
TSHR P16473 2/20 0.43
CYP2C19 P33261 2/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
CYP3A4 P08684 1/20 0.43
PARP1 P09874 1/20 0.43
RECQL P46063 1/20 0.43
BLM P54132 1/20 0.43
PMP22 Q01453 1/20 0.43
HSD17B10 Q99714 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
RAB9A P51151 1/20 0.39
ALDH1A1 P00352 3/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
DAO P14920 1/20 0.37
NAPRT Q6XQN6 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6207028 0.79 CES2 (0.52) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6207821 0.78 CES2 (0.56) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6205112 0.75 CES2 (0.56) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6206775 0.75 CES2 (0.52) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6206848 0.74 CES1 (0.48) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6206843 0.74 CES1 (0.48) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6206851 0.74 CES1 (0.48) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL5073645 0.72 CES2 (0.77) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL1436220 0.71 CES1 (0.60) CES1CES2L3MBTL1TSHRCYP2C19
SCHEMBL6208804 0.70 TSHR (0.48) CES1CES2L3MBTL1TSHRCYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1532128-A1 INHIBITORS OF HCV NS5B POLYMERASE Pharmacia & Upjohn Company LLC (US) 2005-05-25 EP disclosed
WO-2004002977-A1 INHIBITORS OF HCV NS5B POLYMERASE PHARMACIA & UPJOHN COMPANY LLC (US) 2004-01-08 WO disclosed